Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion
Open Access
- 27 August 2014
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5 (19) , 9214-9226
Abstract
Vav1 is a signal transducer that functions as a scaffold protein and a regulator of cytoskeleton organization in the hematopoietic system, where it is exclusively expressed. Recently, Vav1 was shown to be involved in diverse human cancers, including lung cancer. We demonstrate that lung cancer cells that abnormally express Vav1 secrete growth factors in a Vav1-dependent manner. Transcriptome analysis demonstrated that Vav1 depletion results in a marked reduction in the expression of colony-stimulating-factor-1 (CSF1), a hematopoietic growth factor. The association between Vav1 expression and CSF1 was further supported by signal transduction experiments, supporting involvement of Vav1 in regulating lung cancer secretome. Blocking of ERK phosphorylation, led to a decrease in CSF1 transcription, thus suggesting a role for ERK, a downstream effector of Vav1, in CSF1 expression. CSF1-silenced cells exhibited reduced focus formation, proliferation abilities, and growth in NOD/SCID mice. CSF1-silenced H358 cells resulted in significantly smaller tumors, showing increased fibrosis and a decrease in tumor infiltrating macrophages. Finally, immunohistochemical analysis of primary human lung tumors revealed a positive correlation between Vav1 and CSF1 expression, which was associated with tumor grade. Additional results presented herein suggest a potential cross-talk between cancer cells and the microenvironment controlled by CSF1/Vav1 signaling pathways.Keywords
This publication has 52 references indexed in Scilit:
- The potential for targeting extracellular LOX proteins in human malignancyOncoTargets and Therapy, 2013
- Dynamin 2 Potentiates Invasive Migration of Pancreatic Tumor Cells through Stabilization of the Rac1 GEF Vav1Developmental Cell, 2013
- Vav1 Fine Tunes p53 Control of Apoptosis versus Proliferation in Breast CancerPLOS ONE, 2013
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- The EGF/CSF-1 Paracrine Invasion Loop Can Be Triggered by Heregulin β1 and CXCL12Cancer Research, 2009
- Vav1, but not Vav2, contributes to platelet aggregation by CRP and thrombin, but neither is required for regulation of phospholipase CBlood, 2002
- The Activated Macrophage Colony-Stimulating Factor (CSF-1) Receptor as a Predictor of Poor Outcome in Advanced Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptorCurrent Biology, 1998
- Rho proteins induce metastatic properties in vivoOncogene, 1997
- Preferential metabolism of N-nitrosodiethylamine by two cell lines derived from human pulmonary adenocarcinomasCarcinogenesis, 1986